Polynovo Ltd (PNV) Insider Acquires A$58,203.18 in Stock

Polynovo Ltd (ASX:PNV) insider David Williams bought 79,188 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were acquired at an average cost of A$0.74 ($0.52) per share, for a total transaction of A$58,203.18 ($41,278.85).

Shares of ASX PNV remained flat at $A$0.71 ($0.50) during midday trading on Friday. The stock had a trading volume of 2,902,538 shares. Polynovo Ltd has a twelve month low of A$0.46 ($0.32) and a twelve month high of A$0.80 ($0.56). The stock has a market capitalization of $468.66 million and a price-to-earnings ratio of -101.43.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by PressOracle and is owned by of PressOracle. If you are viewing this news story on another site, it was illegally copied and republished in violation of international trademark and copyright laws. The correct version of this news story can be read at https://pressoracle.com/news/2019/03/17/polynovo-ltd-pnv-insider-acquires-a58203-18-in-stock.html.

About Polynovo

Polynovo Limited, a medical device company, designs, develops, and manufactures dermal regeneration solutions in Australia. The company focuses on the development and commercialization of medical devices using its NovoSorb technology in the treatment of burns, surgical wounds, and negative pressure wound therapy.

Further Reading: Commodities

Receive News & Ratings for Polynovo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polynovo and related companies with MarketBeat.com's FREE daily email newsletter.